Crossref
Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia
Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 351-352
DOI: 10.5603/ahp.115371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Bartosz Puła.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Puła, B. (2026). Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia. Acta Haematologica Polonica, 57(5), 351-352. https://doi.org/10.5603/ahp.115371
Vancouver
Puła B. Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia. Acta Haematologica Polonica. 2026;57(5):351-352. doi:10.5603/ahp.115371
BibTeX
@article{Pua2026,
author = {Puła, Bartosz},
title = {Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia},
journal = {Acta Haematologica Polonica},
year = {2026},
volume = {57},
number = {5},
pages = {351--352},
doi = {10.5603/ahp.115371}
}
EUVIMED